The unbound percentage of saquinavir and indinavir remains constant throughout the dosing interval in HIV positive subjects

Abstract

These in vivo data confirm previously published in vitro measurements of SQV and IDV protein binding. The unbound percentage of both protease inhibitors remained constant over the dosing interval.